Cargando…
Inhibition of FGFR3 upregulates MHC‐I and PD‐L1 via TLR3/NF‐kB pathway in muscle‐invasive bladder cancer
BACKGROUND: Improving the potency of immune response is paramount among issues concerning immunotherapy of muscle‐invasive bladder cancer (MIBC). METHODS: On the basis of immune subtypes, we investigated possible molecular mechanisms involved in tumor immune escape in MIBC. According to the 312 immu...
Autores principales: | Wu, WenBo, Chen, Lei, Jia, GaoZhen, Tang, QiLin, Han, BangMin, Xia, ShuJie, Jiang, Qi, Liu, HaiTao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417096/ https://www.ncbi.nlm.nih.gov/pubmed/37283287 http://dx.doi.org/10.1002/cam4.6172 |
Ejemplares similares
-
HSF1 is a novel prognostic biomarker in high-risk prostate cancer that correlates with ferroptosis
por: Jia, GaoZhen, et al.
Publicado: (2023) -
Catalpol Alleviates Depression by Inhibiting NLRP3 Inflammasome via TLR4/MAPK/NF-Kb Pathway
por: Liang, Xuemei, et al.
Publicado: (2023) -
Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer
por: Wu, WenBo, et al.
Publicado: (2021) -
TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy
por: Shen, Jinfeng, et al.
Publicado: (2022) -
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1
por: Forlani, Greta, et al.
Publicado: (2015)